Tao Su

发表

Screening tumor specificity targeted by arnicolide D, the active compound of Centipeda minima and molecular mechanism underlying by integrative pharmacology.

Yaqiu Zheng, Zhongqiu Liu, Yajuan Guo, 2021, Journal of ethnopharmacology.

Tumor Microenvironment Acidity Triggers Lipid Accumulation in Liver Cancer via SCD1 Activation.

Shuwei Zhang, Yaqiu Zheng, Zhongqiu Liu, 2022, Molecular cancer research : MCR.

Centipeda minima: An update on its phytochemistry, pharmacology and safety.

H. Kwan, Ye‐Yeng Wang, Mingjing Meng, 2022, Journal of ethnopharmacology.

Brevilin A is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay

H. Kwan, Zhongqiu Liu, Mingjing Meng, 2023, Journal of Translational Medicine.

Metabolomics Reveals the Mechanisms for the Pulmonary Toxicity of Siegesbeckia orientalis L. and the Toxicity-Reducing Effect of Processing

Ting Zhao, Linsheng Liu, Gang Cao, 2021, Frontiers in Pharmacology.

Omics approach to reveal the effects of obesity on the protein profiles of the exosomes derived from different adipose depots

Fan Zhang, C. Lau, Tiejun Tong, 2022, Cellular and Molecular Life Sciences.

Brevilin A exerts anti-colorectal cancer effects and potently inhibits STAT3 signaling invitro

H. Kwan, Mingjing Meng, Hui-min Chen, 2023, Heliyon.

Therapeutic effects of Siegesbeckia orientalis L. and its active compound luteolin in rheumatoid arthritis: network pharmacology, molecular docking and experimental validation.

H. Kwan, Zhongqiu Liu, Junmao Li, 2023, Journal of ethnopharmacology.

Corrigendum to "Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity" [Pharmacol. Res. (2020) 152 104586].

H. Kwan, Xianjing Hu, Zhongqiu Liu, 2023, Pharmacological research.